Caitlin Raymond: Plasma Chasers and the Quiet Rituals of Apheresis
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, shared on LinkedIn:
”I wrote a new piece this week about something I hadn’t encountered until I became an attending: the “plasma chaser.”
It’s not in ASFA guidelines, not in textbooks, and not something I ever saw in residency or fellowship. But it came up twice in two days, and it made me pause and think about how we make replacement-fluid decisions after recent procedures — and how much of that work happens in the gray space where physiology, experience, and uncertainty meet.
What I found, digging into the peer-reviewed survey data, is striking:
– 8.9% of clinicians still use albumin-only replacement one day after major surgery, a number much higher than I was expecting.
– Clinicians are split about 50/50 on using albumin vs plasma for replacement fluid a day following a minor procedure.
– For a patient scenario with no bleeding risk, 5.3% of clinicians will still use plasma, also higher than I was expecting.
There’s a story in those numbers – about risk perception, about judgment, and about how small, experience-driven practices evolve when formal guidance is limited.
In my blog post, I tried to unpack this… not to prescribe a standard, but to explore how we think through these nuanced decisions and why certain rituals persist in medicine. And also where a rational, physiologic framework can help us cut through the uncertainty.
If you’re interested in the intersection of transfusion medicine, clinical reasoning, and the quiet rituals we inherit in practice, you can read the full piece here.
Would love to hear how others approach post-procedure TPE decisions in their practice – especially where your institution aligns with (or diverges from) the survey data.”

Keep up with Hemostasis Today.
-
Sep 16, 2026, 16:06Katrina Louise Manalaysay: In Your 20s, You Might be Given the Opportunity to Donate Blood for the First Time
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion